Nektar Therapeutics (NKTR)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 04, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Total Assets (Quarterly): 343.33M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 343.33M |
| March 31, 2024 | 396.01M |
| December 31, 2023 | 398.03M |
| September 30, 2023 | 442.24M |
| June 30, 2023 | 494.28M |
| March 31, 2023 | 561.74M |
| December 31, 2022 | 710.60M |
| September 30, 2022 | 781.01M |
| June 30, 2022 | 861.99M |
| March 31, 2022 | 1.024B |
| December 31, 2021 | 1.117B |
| September 30, 2021 | 1.277B |
| June 30, 2021 | 1.371B |
| March 31, 2021 | 1.457B |
| December 31, 2020 | 1.539B |
| September 30, 2020 | 1.509B |
| June 30, 2020 | 1.595B |
| March 31, 2020 | 1.888B |
| December 31, 2019 | 1.977B |
| September 30, 2019 | 2.088B |
| June 30, 2019 | 2.100B |
| March 31, 2019 | 2.166B |
| December 31, 2018 | 2.150B |
| September 30, 2018 | 2.249B |
| June 30, 2018 | 2.313B |
| Date | Value |
|---|---|
| March 31, 2018 | 496.79M |
| December 31, 2017 | 508.87M |
| September 30, 2017 | 582.06M |
| June 30, 2017 | 475.86M |
| March 31, 2017 | 528.49M |
| December 31, 2016 | 568.87M |
| September 30, 2016 | 425.10M |
| June 30, 2016 | 463.10M |
| March 31, 2016 | 491.88M |
| December 31, 2015 | 498.64M |
| September 30, 2015 | 449.25M |
| June 30, 2015 | 456.67M |
| March 31, 2015 | 499.21M |
| December 31, 2014 | 441.62M |
| September 30, 2014 | 476.90M |
| June 30, 2014 | 478.14M |
| March 31, 2014 | 487.01M |
| December 31, 2013 | 434.53M |
| September 30, 2013 | 383.04M |
| June 30, 2013 | 412.81M |
| March 31, 2013 | 447.90M |
| December 31, 2012 | 497.79M |
| September 30, 2012 | 541.45M |
| June 30, 2012 | 668.44M |
| March 31, 2012 | 694.79M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
343.33M
Minimum
Jun 2024
1.977B
Maximum
Dec 2019
1.039B
Average
1.024B
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Esperion Therapeutics Inc | 352.32M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 263.65M |
| Shareholders Equity (Quarterly) | 79.69M |
| Current Ratio | 5.149 |